Follow
Lukas Slipski
Lukas Slipski
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Characteristics associated with the choice of first injectable therapy among US patients with type 2 diabetes
M Yu, R Mody, LF Landó, A Shui, L Kallenbach, L Slipski, CP de Oliveira
Clinical Therapeutics 39 (12), 2399-2408, 2017
192017
Hybrid hyperalignment: A single high-dimensional model of shared information embedded in cortical patterns of response and functional connectivity
EL Busch, L Slipski, M Feilong, JS Guntupalli, MV di Oleggio Castello, ...
NeuroImage 233, 117975, 2021
182021
Patient characteristics and healthcare resource utilization among patients with COPD new to LAMA/LABA fixed-dose combination treatment in US-based real-world practice
B Ding, L Kallenbach, L Slipski, A Wilk, D O’Brien, D Guranlioglu
International Journal of Chronic Obstructive Pulmonary Disease, 775-786, 2020
72020
Clinical and economic burden of eosinophilic COPD in a large retrospective US cohort
F Trudo, L Kallenbach, J Vasey, Y Chung, A Wilk, L Slipski, D O’Brien, ...
International Journal of Chronic Obstructive Pulmonary Disease, 2625-2637, 2019
72019
Characteristics & Glycemic Response of Patients With Uncontrolled Type 2 Diabetes Initiating Dulaglutide Alone or In Combination with Insulin In US Real World Practice
R Mody, L Kallenbach, M Yu, LF Lando, A Shui, L Slipski, D O'Brien
Value in Health 21, S71, 2018
22018
P242 Demographics and clinical characteristics of patients with COPD utilizing LAMA/LABA fixed-dose combination therapy: a US database study
B Ding, L Kallenbach, L Slipski, A Wilk, D O’Brien, D Guranlioglu
Thorax 73 (Suppl 4), A233-A233, 2018
12018
Hybrid Hyperalignment: A Single High-Dimensional Model of Shared Information Embedded in Cortical Patterns of Response and Functional Connectivity
L Slipski
Dartmouth College, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–7